Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Physiological Reports|April 4, 2018
Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteersAnneke P Bech, Jack F M Wetzels, Tom NijenhuisPhysiological Reports|December 8, 2017
Reference values of renal tubular function tests are dependent on age and kidney functionAnneke P Bech, Jack F M Wetzels, Tom NijenhuisJournal of the American Society of Nephrology : JASN|August 31, 2015
Hepatocyte Nuclear Factor 1β-Associated Kidney Disease: More than Renal Cysts and DiabetesJacobien C Verhave, Anneke P Bech, Jack F M Wetzels, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 19, 2014
Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathyAnneke P Bech, Julia M Hofstra, Paul E Brenchley, et al.Journal of the American Society of Nephrology : JASN|July 5, 2017
A Novel Hypokalemic-Alkalotic Salt-Losing Tubulopathy in Patients with CLDN10 MutationsErnie M H F Bongers, Luke M Shelton, Susanne Milatz, et al.Journal of the American Society of Nephrology : JASN|June 30, 2018
The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte InjuryKim A T Verheijden, Ramon Sonneveld, Marinka Bakker-van Bebber, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2020
Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosisDirk J W den Braanker, Rutger J Maas, Jeroen K Deegens, et al.Kidney International|January 4, 2026
Disentangling disease heterogeneity in C3 glomerulopathies: a slippery roadCaroline Duineveld, Jack F M WetzelsPediatric Nephrology (Berlin, Germany)|March 26, 2021
Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptorDaan H H M Viering, Anneke P Bech, Jeroen H F de Baaij, et al.Kidney International|April 17, 2016
Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?Julia M Hofstra, Jack F M WetzelsPageof 26